Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer

Condition:   Squamous Cell Carcinoma of the Head and Neck
Interventions:   Biological: Nivolumab;   Biological: Cetuximab;   Drug: Placebo;   Drug: Cisplatin
Sponsors:   Bristol-Myers Squibb;   ONO Pharmaceutical Co.
Not yet recruiting

http://ift.tt/2AkU2Ez